These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 15076658)

  • 41. The application of two health and productivity instruments at a large employer.
    Ozminkowski RJ; Goetzel RZ; Chang S; Long S
    J Occup Environ Med; 2004 Jul; 46(7):635-48. PubMed ID: 15247802
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P; Whiteford H; Vos T; Bertram M
    J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a composite questionnaire, the valuation of lost productivity, to value productivity losses: application in rheumatoid arthritis.
    Zhang W; Bansback N; Boonen A; Severens JL; Anis AH
    Value Health; 2012 Jan; 15(1):46-54. PubMed ID: 22264971
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Academic achievement and productivity losses associated with speech, language and communication needs.
    Cronin P; Reeve R; McCabe P; Viney R; Goodall S
    Int J Lang Commun Disord; 2020 Sep; 55(5):734-750. PubMed ID: 32687245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absenteeism and Employer Costs Associated With Chronic Diseases and Health Risk Factors in the US Workforce.
    Asay GR; Roy K; Lang JE; Payne RL; Howard DH
    Prev Chronic Dis; 2016 Oct; 13():E141. PubMed ID: 27710764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Productivity cost calculations in health economic evaluations: correcting for compensation mechanisms and multiplier effects.
    Krol M; Brouwer WB; Severens JL; Kaper J; Evers SM
    Soc Sci Med; 2012 Dec; 75(11):1981-8. PubMed ID: 22925428
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The burden of systemic juvenile idiopathic arthritis for patients and caregivers: an international survey and retrospective chart review.
    Shenoi S; Horneff G; Cidon M; Ramanan AV; Kimura Y; Quartier P; Foeldvari I; Zeft A; Lomax KG; Gregson J; Abma T; Campbell-Hill S; Weiss J; Patel D; Marinsek N; Wulffraat N
    Clin Exp Rheumatol; 2018; 36(5):920-928. PubMed ID: 29600940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Health and productivity as a business strategy: a multiemployer study.
    Loeppke R; Taitel M; Haufle V; Parry T; Kessler RC; Jinnett K
    J Occup Environ Med; 2009 Apr; 51(4):411-28. PubMed ID: 19339899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Productivity loss due to absenteeism and presenteeism by different instruments in patients with RA and subjects without RA.
    Braakman-Jansen LM; Taal E; Kuper IH; van de Laar MA
    Rheumatology (Oxford); 2012 Feb; 51(2):354-61. PubMed ID: 22179729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. United States Patients' Perspective of Living With Migraine: Country-Specific Results From the Global "My Migraine Voice" Survey.
    Gibbs SN; Shah S; Deshpande CG; Bensink ME; Broder MS; Dumas PK; Buse DC; Vo P; Schwedt TJ
    Headache; 2020 Jul; 60(7):1351-1364. PubMed ID: 32369201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Costs and absence of HCV-infected employees by disease stage.
    Baran RW; Samp JC; Walker DR; Smeeding JE; Young JW; Kleinman NL; Brook RA
    J Med Econ; 2015; 18(9):691-703. PubMed ID: 26047262
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pain exacerbation as a major source of lost productive time in US workers with arthritis.
    Ricci JA; Stewart WF; Chee E; Leotta C; Foley K; Hochberg MC
    Arthritis Rheum; 2005 Oct; 53(5):673-81. PubMed ID: 16208644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modeling the impact of enhanced depression treatment on workplace functioning and costs: a cost-benefit approach.
    Lo Sasso AT; Rost K; Beck A
    Med Care; 2006 Apr; 44(4):352-8. PubMed ID: 16565636
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Job Absenteeism Costs of Obesity in the United States: National and State-Level Estimates.
    Cawley J; Biener A; Meyerhoefer C; Ding Y; Zvenyach T; Smolarz BG; Ramasamy A
    J Occup Environ Med; 2021 Jul; 63(7):565-573. PubMed ID: 33769330
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost of lost productive work time among US workers with depression.
    Stewart WF; Ricci JA; Chee E; Hahn SR; Morganstein D
    JAMA; 2003 Jun; 289(23):3135-44. PubMed ID: 12813119
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The relationship between chronic conditions and absenteeism and associated costs in Canada.
    Zhang W; McLeod C; Koehoorn M
    Scand J Work Environ Health; 2016 Sep; 42(5):413-22. PubMed ID: 27510927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Illness related wage and productivity losses: Valuing 'presenteeism'.
    Zhang W; Sun H; Woodcock S; Anis A
    Soc Sci Med; 2015 Dec; 147():62-71. PubMed ID: 26547046
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Valuing reductions in on-the-job illness: 'presenteeism' from managerial and economic perspectives.
    Pauly MV; Nicholson S; Polsky D; Berger ML; Sharda C
    Health Econ; 2008 Apr; 17(4):469-85. PubMed ID: 17628862
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Attendance dynamics at work: the antecedents and correlates of presenteeism, absenteeism, and productivity loss.
    Johns G
    J Occup Health Psychol; 2011 Oct; 16(4):483-500. PubMed ID: 21875212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.